Latest Regulatory News

James Hardie Industries reports a 34% jump in Q2 FY26 net sales driven by the AZEK acquisition and European growth, while grappling with margin pressures and integration costs.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.

Radiopharm Theranostics has secured ethics approval to begin a Phase 1 clinical trial of RAD 402, a pioneering radiotherapeutic targeting advanced prostate cancer using terbium-161. This marks a significant step in developing a potentially safer, more effective treatment option.

Plenti Group Limited has reported a remarkable half-year performance for FY26, with revenues up 20% and profit soaring over tenfold to $10.5 million. The fintech lender’s loan portfolio expanded 24%, driven by strong demand across automotive, renewable energy, and personal loans.

Nexus Minerals reports robust one-metre assay results from Clement and Godfrey prospects, confirming significant gold mineralisation at Wallbrook. The Crusader-Templar Mine Development and Closure Plan has secured regulatory approval, paving the way for operational progress.

SQX Resources has reported exceptional high-grade gold and silver assays from underground sampling at the Williams Project in Montana, validating historical data and advancing its acquisition of AM6 Pty Ltd.

Dalaroo Metals has appointed seasoned mining executive John Morgan as CEO, signaling a strategic push to advance its exploration projects across multiple continents. His performance-linked incentives align leadership rewards with shareholder value creation.

Lunnon Metals has updated its Lady Herial gold resource to 36,300 ounces at 2.0 g/t, securing Gold Fields’ approval and nearing regulatory green light for mining.

K2 Asset Management Holdings Ltd marked a pivotal year with 17% revenue growth and a return to profitability, declaring a fully franked dividend and outlining ambitious growth plans across its core business pillars.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

RPMGlobal shareholders are set to vote on Caterpillar’s $5.00 per share acquisition proposal following Federal Court approval to convene a Scheme Meeting. The Independent Expert deems the offer fair and reasonable, with the RPM Board unanimously backing the deal.